Related Experiment Video

Updated: Mar 11, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

19.1K

FAT4 functions as a tumor suppressor in triple-negative breast cancer

Lingmi Hou1,2,3, Maoshan Chen4, Xiaobo Zhao2

  • 1Breast Disease Center, Southwest Hospital, Third Military Medical University, Chongqing, 40038, China.

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|November 30, 2016
PubMed

Insights

FAT4 acts as a tumor suppressor in triple-negative breast cancer (TNBC). Repressing FAT4 promotes TNBC progression, suggesting FAT4 as a potential therapeutic target for this aggressive cancer subtype.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Triple-negative breast cancer (TNBC) is an aggressive subtype characterized by frequent distant metastasis.
  • The role of FAT tumor suppressor homolog 4 (FAT4) in TNBC pathogenesis remains largely unelucidated.
  • FAT4, a cadherin-related protein, is recognized for its tumor-suppressive functions in various biological contexts.

Purpose of the Study:

  • To investigate the functional role of FAT4 in TNBC.
  • To elucidate the molecular mechanisms underlying FAT4's involvement in TNBC.
  • To evaluate FAT4 as a potential therapeutic target for TNBC.

Main Methods:

  • Immunohistochemistry, western blotting, and qRT-PCR were employed to assess FAT4 expression in TNBC tissues.
  • MTT assays were utilized to evaluate the impact of FAT4 on cell proliferation.
  • Migration and invasion assays were performed to assess the effects of FAT4 on TNBC cell motility.

Main Results:

  • FAT4 expression was evaluated in TNBC tissues.
  • Repression of FAT4 using shRNA was observed to promote TNBC progression.
  • FAT4's influence on cell proliferation, migration, and invasion was assessed.

Conclusions:

  • FAT4 functions as a tumor suppressor in triple-negative breast cancer.
  • Downregulation of FAT4 correlates with enhanced TNBC progression.
  • The FAT4 cluster represents a promising therapeutic target for TNBC treatment.
Keywords:
FAT4InvasionProliferationTNBC

More Related Videos

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

19.2K
Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module10:39

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

13.9K

Related Concept Videos

Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.2K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K